Article
Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma.
The oncologist - 17 Jan 2025
Yousef Mahmoud, Hurd Mark W, Yousef Abdelrahman, Ludmir Ethan B, Pillai Ashwathy B, Peterson Jennifer, Koay Eugene J, Albarouki Sali, Tzeng Ching-Wei, Snyder Rebecca, Katz Matthew H G, Wang Huamin, Overman Michael J, Maitra Anirban, Pant Shubham, Smaglo Brandon G, Wolff Robert A, Yao James, Shen John P, Zhao Dan
Abstract excerpt
BACKGROUND: The prognosis for patients with pancreatic ductal adenocarcinoma (PDAC) is poor. Secondary brain metastasis (Br-M) occurs in less than 1% of patients. Clinical characteristics and molecular alterations have not been characterized in this rare patients' subset. MATERIALS AND METHODS: The Foundry software platform was used to retrospectively query electronic health records for patients with Br-M...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
